Matinas BioPharma
assessment of efficacy against | Matinas BioPharma
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
26 of 31
Similar slides by Matinas BioPharma
See diffirences between slides (animation)
Investor Presentation
November 2023
in efficacy against | Matinas BioPharma
Related slides by other companies
Oculis
Investor Presentation
July 2023
towards the assessment of the efficacy of in patients phase acuity trial in acute optic neuritis | Oculis
MAIA Biotechnology
Investor Presentation
January 2024
excellent efficacy in models liver cancer | MAIA Biotechnology
Erasca
Investor Presentation
January 2024
| Erasca
Recursion Pharmaceuticals
Investor Day
January 2023
clinical efficacy found in in mice models led to significant progression free survival further confidence preclinical studies confirming insight | Recursion Pharmaceuticals
Other recent decks by Matinas BioPharma
See all presentations (7 decks)
Investor Presentation
March 2024
Investor Presentation
February 2024
Investor Presentation
January 2024
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io